{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T22:05:20Z","timestamp":1768255520041,"version":"3.49.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1974,11,1]],"date-time":"1974-11-01T00:00:00Z","timestamp":152496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1974,11,1]],"date-time":"1974-11-01T00:00:00Z","timestamp":152496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1974,11]]},"DOI":"10.1136\/ard.33.6.532","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"532-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report."],"prefix":"10.1016","volume":"33","author":[{"given":"E.C","family":"Huskisson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.J","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.W","family":"Balme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.C","family":"Burry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Grahame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.D","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.R","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A","family":"Wojtulewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","first-page":"264","article-title":"(Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis)","volume":"4","author":"BOARDMAN, P.L.; HART, F.D.","year":"1967","unstructured":"BOARDMAN, P. L., AND HART, F. D. (1967), Brit. med. J., 4, 264 (Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis)","journal-title":"J"},{"key":"ref_2","first-page":"49","article-title":"COMMITTEE OF THE AMERICAN RHEUMATISM","volume":"18","author":"Dis.,","year":"1959","unstructured":"COMMITTEE OF THE AMERICAN RHEUMATISM ASSOCIATION (1959) Ann. rheum. Dis., 18, 49 (Diagnostic criteria for rheumatoid arthritis: 1958 revision)","journal-title":"ASSOCIATION; Ann. rheum"},{"key":"ref_3","first-page":"275","article-title":"(Controlled trial of D-penicillamine in severe rheumatoid arthritis)","volume":"1","author":"GROUP, M.U.L.T.I.C.E.N.T.R.E.T.R.I.A.L.","year":"1973","unstructured":"MULTICENTRE TRIAL GROUP (1973) Lancet, 1, 275 (Controlled trial of D-penicillamine in severe rheumatoid arthritis)"},{"key":"ref_4","first-page":"393","article-title":"(Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis)","volume":"37","author":"RITCHIE, D.M.; BOYLE, J.A.; MCINNES, J.M.; JASANI, M.K.; DALAKOS, T.G.; GRIEVESON, P.; BUCHANAN, W.W.","year":"1968","unstructured":"RITCHIE, D. M., BOYLE, J. A., MCINNES, J. M., JASANI, M. K., DALAKOS, T. G., GRIEVESON, P., AND BUCHANAN, W. W. (1968) Quart. J. Med., 37, 393 (Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis)","journal-title":"Quart. J. Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724411308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724411308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.33.6.532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T12:01:32Z","timestamp":1737547292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724411308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1974,11]]},"references-count":4,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1974,11]]}},"alternative-id":["S0003496724411308"],"URL":"https:\/\/doi.org\/10.1136\/ard.33.6.532","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1974,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.33.6.532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1974 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}